Structural optimization of new class of selective carbonic anhydrase inhibitors: QSAR approach

被引:0
作者
Pothen, Blessy [1 ]
Singh, Vineet [1 ]
Kumar, Surendra [1 ]
Tiwari, Meena [1 ]
机构
[1] Shri Govindram Seksaria Inst Technol & Sci, Comp Aided Drug Design Lab, Dept Pharm, Indore 452003, Madhya Pradesh, India
来源
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY | 2010年 / 49卷 / 02期
关键词
Sulfonamide; carbonic anhydrase; antiglaucoma; anticancer; quantitative structure activity relationship; ISOZYME-II; X-RAY; ANTITUMOR SULFONAMIDE; CRYSTAL-STRUCTURE; BINDING-SITE; CA-VII; EXPRESSION; AFFINITY;
D O I
暂无
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Quantitative structure activity relationship studies have been conducted on a series (24 compounds) of sulfonamide derivatives with selective carbonic anhydrase inhibitory activity using ChemOffice v.8.0 software. The best predictions have been obtained for hCA-II enzyme inhibition activity (Q(2) = 0.552, r(2) = 0.724) and with hCA-VII enzyme inhibition activity (Q(2) = 0.501, r(2) = 0.704). Both equations are validated by a test set of compounds and give satisfactory predictive r(2) values of 0.434, and 0.608, respectively. The equations selected emphasized the importance of LogP (octanol/water partition coefficient). Highest Occupied Molecular Orbital (HOMO) and Radius of gyration (Rgy) on biological activity i.e., hydrophobic groups, presence of electron donating groups, size and shape of molecule might be influencing the selective carbonic anhydrase inhibitory activity.
引用
收藏
页码:224 / 233
页数:10
相关论文
共 30 条
  • [21] Scozzafava A, 2004, EXPERT OPIN THER PAT, V14, P667, DOI 10.1517/eotp.14.5.667.31276
  • [22] Stams T, 2000, EXS, V90, P159
  • [23] Carbonic anhydrases as targets for medicinal chemistry
    Supuran, Claudiu T.
    Scozzafava, Andrea
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (13) : 4336 - 4350
  • [24] Supuran Claudiu T., 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P49, DOI 10.2174/1568016043477305
  • [25] Supuran CT, 2004, CRC ENZYM INHIB SER, P1, DOI 10.1201/9780203475300.ch1
  • [26] Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides
    Vullo, D
    Voipio, J
    Innocenti, A
    Rivera, C
    Ranki, H
    Scozzafava, A
    Kaila, K
    Supuran, CT
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) : 971 - 976
  • [27] Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition
    Weber, A
    Casini, A
    Heine, A
    Kuhn, D
    Supuran, CT
    Scozzafava, A
    Klebe, G
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) : 550 - 557
  • [28] Expression, assay, and structure of the extracellular domain of murine carbonic anhydrase XIV - Implications for selective inhibition of membrane-associated isozymes
    Whittington, DA
    Grubb, JH
    Waheed, A
    Shah, GN
    Sly, WS
    Christianson, DW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) : 7223 - 7228
  • [29] Carbonic anhydrase inhibitors: Clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue
    Winum, Jean-Yves
    Temperini, Claudia
    El Cheikh, Khaled
    Innocenti, Alessio
    Vullo, Daniela
    Ciattini, Samuele
    Montero, Jean-Louis
    Scozzafava, Andrea
    Supuran, Claudiu T.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) : 7024 - 7031
  • [30] WOLD S, 1995, QSAR CHEMOMETRIC MET, V2, P321